Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-02 Sale |
2021-12-03 5:15 pm |
SELLAS Life Sciences Group Inc. | SLS | Stergiou Angelos M. President and CEO |
2,120 | $6.2509 | $13,252 | 121,167 (Direct) |
View |
| 2021-12-02 Sale |
2021-12-03 5:14 pm |
SELLAS Life Sciences Group Inc. | SLS | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. |
847 | $6.2547 | $5,298 | 42,028 (Direct) |
View |
| 2021-12-02 Sale |
2021-12-03 5:13 pm |
SELLAS Life Sciences Group Inc. | SLS | Burns John Thomas VP, Finance & Corp Controller |
231 | $6.2673 | $1,448 | 17,644 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2022-03-14 4:19 pm |
N/A N/A |
SELLAS Life Sciences Group Inc. | SLS | Francomano Robert Chief Commercial Officer |
0 | $0 | 0 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-01 5:07 pm |
N/A 2032-01-31 |
SELLAS Life Sciences Group Inc. | SLS | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. |
61,750 | $0 | 103,778 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-01 5:07 pm |
N/A 2032-01-31 |
SELLAS Life Sciences Group Inc. | SLS | Wasman Jane Director |
9,025 | $0 | 9,025 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-01 5:06 pm |
N/A 2032-01-31 |
SELLAS Life Sciences Group Inc. | SLS | Varian John Director |
9,025 | $0 | 9,025 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-01 5:06 pm |
N/A 2032-01-31 |
SELLAS Life Sciences Group Inc. | SLS | VAN NOSTRAND ROBERT L Director |
9,025 | $0 | 9,025 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-01 5:06 pm |
N/A 2032-01-31 |
SELLAS Life Sciences Group Inc. | SLS | Stergiou Angelos M. President and CEO |
209,000 | $0 | 330,167 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-01 5:05 pm |
N/A 2032-01-31 |
SELLAS Life Sciences Group Inc. | SLS | SCHEINBERG DAVID A Director |
9,025 | $0 | 9,207 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-01 5:05 pm |
N/A 2032-01-31 |
SELLAS Life Sciences Group Inc. | SLS | Burns John Thomas Senior VP, Finance & CAO |
45,600 | $0 | 63,244 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 4:51 pm |
N/A 2031-03-04 |
SELLAS Life Sciences Group Inc. | SLS | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. |
55,125 | $0 | 80,125 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 4:30 pm |
N/A 2031-03-04 |
SELLAS Life Sciences Group Inc. | SLS | SCHEINBERG DAVID A Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 4:29 pm |
N/A 2031-03-04 |
SELLAS Life Sciences Group Inc. | SLS | Varian John Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 4:29 pm |
N/A 2031-03-04 |
SELLAS Life Sciences Group Inc. | SLS | Wasman Jane Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 4:28 pm |
N/A 2031-03-04 |
SELLAS Life Sciences Group Inc. | SLS | VAN NOSTRAND ROBERT L Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 4:28 pm |
N/A 2031-03-04 |
SELLAS Life Sciences Group Inc. | SLS | Burns John Thomas VP, Finance & Corp Controller |
20,125 | $0 | 30,125 (Direct) |
View |
| 2021-03-04 Option Award |
2021-03-08 4:26 pm |
N/A 2031-03-04 |
SELLAS Life Sciences Group Inc. | SLS | Stergiou Angelos M. President and CEO |
138,250 | $0 | 216,787 (Direct) |
View |